2 exciting ASX growth shares to buy next month

ELMO Software Ltd (ASX:ELO) and this ASX growth share could be ones to buy right now. Here's why they are rated highly…

| More on:
new tech shares represented by US dollars hatching out of golden egg

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Are you looking to add a growth share or two to your portfolio next month? Then take a look at the two ASX shares listed below.

Here's why they could be growth shares to buy right now:

ELMO Software Ltd (ASX: ELO)

ELMO is a cloud-based human resources and payroll software company that provides businesses with a unified platform to streamline a wide range of processes.

It has been a strong performer in recent years and pleasingly this continued in FY 2021 despite the pandemic. Last month ELMO released its half year results and revealed that its annualised recurring revenue (ARR) had grown to $74.2 million. This was driven by a combination of organic growth and the benefits of acquisitions that have strengthened its offering and increased its addressable market.

Morgan Stanley was pleased with its half year results and put an overweight rating and $9.70 price target on its shares. It is confident on its second half prospects and appears confident it will achieve its FY 2021 guidance.

Pro Medicus Limited (ASX: PME)

Another growth share to look at is Pro Medicus. It is a healthcare technology company that provides radiology information systems (RIS), picture archiving and communication systems (PACS), and advanced visualisation solutions to healthcare organisations globally.

It has been performing positively during the pandemic and reported strong revenue and profit growth last month. For the six months ended 31 December, Pro Medicus delivered a 7.8% increase in revenue to $31.6 million and a 25.9% jump in underlying profit before tax to $18.76 million.

Pleasingly, since the end of the half the company has won a number of lucrative long term contracts with major healthcare institutions. And thanks to its industry-leading software, its sizeable market opportunity, and the shift away from legacy systems, it wouldn't be a surprise to see more contract wins in the coming months. 

Goldman Sachs is a fan and recently upgraded Pro Medicus' shares to a buy rating with a $53.80 price target. It believes it is well-positioned to grow its earnings at a rapid rate over the coming years.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and recommends Elmo Software and Pro Medicus Ltd. The Motley Fool Australia has recommended Elmo Software and Pro Medicus Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Growth Shares

Man pointing an upward line on a bar graph symbolising a rising share price.
Growth Shares

4 top ASX growth shares to buy and hold

Analysts think these stocks are in the buy zone right now.

Read more »

Young woman using computer laptop smiling in love showing heart symbol and shape with hands. as she switches from a big telco to Aussie Broadband which is capturing more market share
Growth Shares

Here are 4 exciting ASX growth stocks that brokers love in 2024

Brokers think investors should be snapping up these growth stocks.

Read more »

A girl is handed an oversized ice cream cone with lots of different flavours.
Growth Shares

How I'd use ASX growth shares to turn $1,000 into $10,000

Choosing the right growth shares can add plenty of bang to your buck.

Read more »

a man in a business suit points his finger amid a digitised map of the globe suspended in the air in front of him, complete with graphs, digital code and glyphs to indicate digital assets.
Investing Strategies

Future focus: How to diversify your portfolio with ASX AI ETFs

Looking for a simple and effective way to capitalise on the growth of AI technologies across global markets?

Read more »

chart showing an increasing share price
Growth Shares

Buy these excellent ASX growth shares for 15% to 20% returns

Analysts think big returns could be on the cards for owners of these shares.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Growth Shares

These ASX 200 growth shares could rise 12% to 30%

Analysts think big returns could be on offer from these shares.

Read more »

Man in an office celebrates at he crosses a finish line before his colleagues.
Growth Shares

Hoping to beat the ASX 200? I'd consider buying these 3 ASX shares

Analysts think these shares can outperform the market.

Read more »

a happy investor with a wide smile points to a graph that shows an upward trending share price
Growth Shares

5 top ASX growth shares to buy in April

Analysts think growth investors should be buying these shares.

Read more »